Search - tctmd.com

Displaying 141 - 160 of 166

Sort: Relevancy | Date

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Industry News

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

May 23, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

News Daily News

CT Scans Cause Delays in Care When Performed Prior to Primary PCI

Jason Kahn

May 04, 2012

News Daily News

Study Focuses on Systemic Inflammation After TAVR

Caitlin E. Cox

March 07, 2012

News Daily News

Estudio se Centra en la Inflamación Sistémica tras la TAVR

Caitlin E. Cox

March 07, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

Presentation TCT 2012

Female Patients with Acute Coronary Syndrome: Two Years Clinical Outcomes.

Presenter: Philip Urban, Osmund Bertel, Olivier Darremont, Nicos Spyrou, Vincenzo Filippone, Francesco Romea, Do Quan Huan, Ahmet Tastan, Andre Georges Vuilliomenet, Xu-Ming Zhang, Gian Battista Danzi

January 03, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Relationship Between Plaque Composition Assessed With Radiofrequency IVUS and Clinical Outcomes in Patients with Acute Coronary Syndromes and Diabetes Mellitus or Metabolic...

Presenter: Steven P. Marso, Nestor Mercado, Akiko Maehara, Giora Weisz, Gary Mintz, John McPherson, Francois Schiele, Dariusz Dudek, Martin Fahy, Ke Xu, Alexandra Lansky, Bernard de Bruyne, Patrick Serruys, Gregg Stone

January 03, 2012

Presentation TCT 2012

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Presenter: Patrick Tobbia, Bruce R. Brodie, Thomas Stuckey, Brent T. McLaurin, David Cox, Martin Fahy, Ke Xu, Roxana Mehran, Gregg W. Stone

January 03, 2012

Presentation TCT 2012

Age and Sex Related Plaque Composition Of Non Culprit Lesions In Patients with Acute Coronary Syndromes: The PROSPECT Study.

Presenter: Juan Ruiz Garc?a, Amir Lerman, Giora Weisz, Akiko Maehara, Gary S. Mintz, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Tony G. Farah, Rui Teles, Hans Botker, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Daily News

Hope Renewed for Novel Anticoagulant Use in ACS

Caitlin E. Cox

October 05, 2011

News Conference News

News Daily News

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

L.A. McKeown

June 10, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

Advertisement

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

CT Scans Cause Delays in Care When Performed Prior to Primary PCI

Study Focuses on Systemic Inflammation After TAVR

Estudio se Centra en la Inflamación Sistémica tras la TAVR

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Female Patients with Acute Coronary Syndrome: Two Years Clinical Outcomes.

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Relationship Between Plaque Composition Assessed With Radiofrequency IVUS and Clinical Outcomes in Patients with Acute Coronary Syndromes and Diabetes Mellitus or Metabolic...

Are Adverse Events Following an Invasive Strategy in Patients with Non ST-Segment Elevation Acute Coronary Syndromes (NSTEACS) More Frequent at US Sites vs Non US Sites...

Age and Sex Related Plaque Composition Of Non Culprit Lesions In Patients with Acute Coronary Syndromes: The PROSPECT Study.

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Hope Renewed for Novel Anticoagulant Use in ACS

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Apixaban Increases Major Bleeding in High-Risk ACS Patients

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content